These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16138439)

  • 41. Imipenem-cilastatin sodium.
    Roach AC
    Crit Care Nurse; 1989 Mar; 9(3):14-8. PubMed ID: 2582800
    [No Abstract]   [Full Text] [Related]  

  • 42. Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.
    Sims M; Mariyanovski V; McLeroth P; Akers W; Lee YC; Brown ML; Du J; Pedley A; Kartsonis NA; Paschke A
    J Antimicrob Chemother; 2017 Sep; 72(9):2616-2626. PubMed ID: 28575389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical evaluation of imipenem/cilastatin sodium in infectious complications of hematological malignancies. Tohkai Research Group on Infections in Hematological Disorders].
    Naito K; Kobayashi M; Okumura M; Ikeda Y; Mitomo Y; Oguri T; Tanaka M; Ohara K; Kodera Y; Ohno R
    Jpn J Antibiot; 1990 Aug; 43(8):1371-80. PubMed ID: 2283705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
    Uhari M; Seppänen J; Heikkinen E
    Pediatr Infect Dis J; 1992 Jun; 11(6):445-50. PubMed ID: 1608680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F; Faulkner KL
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cross-reactivity and tolerability of imipenem in patients with delayed-type, cell-mediated hypersensitivity to beta-lactams.
    Schiavino D; Nucera E; Lombardo C; Decinti M; Pascolini L; Altomonte G; Buonomo A; Patriarca G
    Allergy; 2009 Nov; 64(11):1644-8. PubMed ID: 19392998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First- and second-derivative spectrophotometric determination of imipenem and cilastatin in injections.
    Parra A; Garcia-Villanova J; Ródenas V; Gómez MD
    J Pharm Biomed Anal; 1993 Jun; 11(6):477-82. PubMed ID: 8399518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study.
    Fabian TC; File TM; Embil JM; Krige JE; Klein S; Rose A; Melnick D; Soto NE
    Surg Infect (Larchmt); 2005; 6(3):269-82. PubMed ID: 16201937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overall clinical utility of the intramuscular preparation of imipenem/cilastatin.
    MacGregor RR
    Chemotherapy; 1991; 37 Suppl 2():53-7. PubMed ID: 1879188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pustular eruption after drug exposure: is it pustular psoriasis or a pustular drug eruption?
    Spencer JM; Silvers DN; Grossman ME
    Br J Dermatol; 1994 Apr; 130(4):514-9. PubMed ID: 8186121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
    Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incompatibility of imipenem-cilastatin and amoxicillin.
    Pourroy B; Bausset EM; Boulamery A; Villano LG; Braguer D
    Am J Health Syst Pharm; 2009 Jul; 66(14):1253-4. PubMed ID: 19574595
    [No Abstract]   [Full Text] [Related]  

  • 54. Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia.
    Gorman SK; Zed PJ; Dhingra VK; Ronco JJ
    Ann Pharmacother; 2003 Apr; 37(4):513-6. PubMed ID: 12659606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of imipenem-cilastatin in pediatrics.
    Overturf GD
    Pediatr Infect Dis J; 1989 Nov; 8(11):792-4. PubMed ID: 2687788
    [No Abstract]   [Full Text] [Related]  

  • 56. Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients.
    Engervall P; Günther G; Ljungman P; Lönnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Björkholm M
    J Chemother; 1996 Oct; 8(5):382-6. PubMed ID: 8957719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Short-term perioperative antibacterial prophylaxis using imipenem-cilastatin versus acylureide penicillins in pacemaker implantation. A 30-month follow-up].
    Veneziani N; De Pasquale C; Baglietto M
    Clin Ter; 1992 May; 140(5):481-5. PubMed ID: 1424488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
    Vural S; Erdem E; Gulec SG; Yildirmak Y; Kebudi R
    Pediatr Int; 2010 Apr; 52(2):262-7. PubMed ID: 19744230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of imipenem/cilastatin for treatment of infection in an elderly population.
    Smith MD; Bielawska C; Kelsey MC; Rai G; Deaney NB
    J Antimicrob Chemother; 1988 Apr; 21(4):481-7. PubMed ID: 3378960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)].
    Figuera A ; Rivero N; Pajuelo F; Font P; Leyra F; de La Cámara R; Arranz R; María Fernández Rañada J
    Med Clin (Barc); 2001 May; 116(16):610-1. PubMed ID: 11412645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.